- Author:
Woo Jung SONG
1
;
Ji Won KWON
;
Eun Jin KIM
;
Sang Min LEE
;
Sae Hoon KIM
;
So Yeon LEE
;
Sang Heon KIM
;
Heung Woo PARK
;
Yoon Seok CHANG
;
Woo Kyung KIM
;
Jung Yeon SHIM
;
Ju Hee SEO
;
Byoung Ju KIM
;
Hyo Bin KIM
;
Dae Jin SONG
;
Gwang Cheon JANG
;
An Soo JANG
;
Jung Won PARK
;
Ho Joo YOON
;
Joo Shil LEE
;
Sang Heon CHO
;
Soo Jong HONG
Author Information
- Publication Type:Review
- Keywords: Exhaled nitric oxide; reference value; guideline; position paper; asthma
- MeSH: Asthma; Ethnic Groups; Humans; Nitric Oxide*; Reference Values
- From:Allergy, Asthma & Immunology Research 2015;7(1):3-13
- CountryRepublic of Korea
- Language:English
- Abstract: Nitric oxide (NO) is a biologic mediator of various physiologic functions. Recent evidence suggests the clinical utility of fractional exhaled NO (FeNO) as a biomarker for assessing asthma and other respiratory diseases. FeNO methodologies have been recently standardized by international research groups and subsequently validated in several Korean population studies. Normal ranges for FeNO have been reported for various ethnic groups, and the clinical utility has been widely evaluated in asthma and various respiratory diseases. Based on current evidence including most of Korean population data, this position paper aims to introduce the methodological considerations, and provide the guidance for the proper clinical application of FeNO measurements in Korean populations.